Nestlé's shares drop 3.2% as analysts lower forecasts, highlighting self-inflicted challenges and recent leadership changes.
Tag: Financial Outlook
Post
Mrna Stock- Moderna Faces Challenges Post-COVID: Major R&D Budget Cuts Announced
What are Moderna's upcoming respiratory vaccines and how could they transform COVID-19, flu, and RSV prevention?
